Vaccination with EGF active immunotherapy improves survival in advanced non small cell lung cancer (NSCLC) patients: Interim analysis of a randomized phase II trial

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7210-7210
Author(s):  
E. Neninger ◽  
T. Crombet ◽  
M. Osorio ◽  
M. Catala ◽  
A. Torre ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Interim Analysis ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Active Immunotherapy ◽  
Small Cell Lung ◽  
Randomized Phase Ii ◽  
Nsclc Patients

scholarly journals Randomized Phase II Trial of Sequential Chemotherapy in Advanced Non-Small Cell Lung Cancer (SWOG 9806)

2004 ◽  
Vol 10 (15) ◽  
pp. 5022-5026 ◽  
Author(s):  
Martin J. Edelman ◽  
Joseph I. Clark ◽  
Kari Chansky ◽  
Kathy Albain ◽  
Nirmala Bhoopalam ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Sequential Chemotherapy ◽  
Randomized Phase Ii

A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non???Small-Cell Lung Cancer

2006 ◽  
Vol 1 (1) ◽  
pp. 19-24 ◽  
Author(s):  
Gregory A. Masters ◽  
Athanassios E. Argiris ◽  
Elizabeth A. Hahn ◽  
J Thaddeus Beck ◽  
P Gregory Rausch ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document